socalTECH
MAY 16, 2014
The pricing was below the company''s earlier, estimated IPO range of $12.00 The company raised around $71.1M TrueCar is venture backed by backed by USAA, Capricorn Investment Group, Upfront Ventures, Anthem Ventures, Vulcan Capital Growth Equity, Peppy Capital Partners, Arcturus Venture Capital, along with others.
Xconomy
APRIL 17, 2020
The public markets are moving erratically, but Alnylam Pharmaceuticals showed this week that selling equity isn’t the only way for biotech companies to raise cash. Late last year Alnylam (NASDAQ: ALNY ) began exploring potential royalty deals for inclisiran, a drug that uses RNA interference to lower cholesterol.
Expert insights. Personalized for you.
147 
Let's personalize your content